Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V

Christian Baumgartner, Sabine Cerny-Reiterer, Karoline Sonneck, Matthias Mayerhofer, Karoline V Gleixner, Richard Fritz, Marc Kerenyi, Cedric Boudot, Fabrice Gouilleux, Jan-Wilhelm Kornfeld, Christian Sillaber, Richard Moriggl, Peter Valent

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

Recent data suggest that the signal transducer and activator of transcription (STAT)5 contributes to differentiation and growth of mast cells. It has also been described that constitutively phosphorylated STAT5 (pSTAT5) plays a pro-oncogenic role in various myeloid neoplasms. We examined the expression of pSTAT5 in neoplastic mast cells in systemic mastocytosis and asked whether the disease-related oncoprotein KIT D816V is involved in STAT5 activation. As assessed by immunohistochemistry using the anti-pSTAT5 antibody AX1, neoplastic mast cells were found to display pSTAT5 in all SM patients examined (n = 40). Expression of pSTAT5 was also demonstrable in the KIT D816V-positive mast cell leukemia cell line HMC-1. Using various staining-protocols, pSTAT5 was found to be located in both the cytoplasmic and nuclear compartment of mast cells. To define the functional role of KIT D816V in STAT5-activation, Ba/F3 cells with doxycycline-inducible expression of KIT D816V were used. In these cells, induction of KIT D816V resulted in an increased expression of pSTAT5 without substantial increase in total STAT5. Moreover, the KIT D816V-targeting kinase-inhibitor PKC412 was found to counteract expression of pSTAT5 in HMC-1 cells as well as doxycycline-induced expression of pSTAT5 in Ba/F3 cells. Finally, a dominant negative STAT5-construct was found to inhibit growth of HMC-1 cells. Together, our data show that neoplastic mast cells express cytoplasmic and nuclear pSTAT5, that KIT D816V promotes STAT5-activation, and that STAT5-activation contributes to growth of neoplastic mast cells.

OriginalsprogEngelsk
TidsskriftThe American Journal of Pathology
Vol/bind175
Udgave nummer6
Sider (fra-til)2416-2429
ISSN0002-9440
DOI
StatusUdgivet - dec. 2009
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V'. Sammen danner de et unikt fingeraftryk.

Citationsformater